| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.0032 | 1 |